Proteases as Targets for Therapy

  • Klaus von der Helm
  • Bruce D. Korant
  • John C. Cheronis

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 140)

Table of contents

  1. Front Matter
    Pages I-XXVIII
  2. Human Immunodeficiency Virus Protease Inhibitors

  3. Other Viral (Non-HIV) Protease Inhibitors

    1. Front Matter
      Pages 73-73
    2. C. Steinkühler, U. Koch, R. De Francesco, A. Pessi
      Pages 75-94
    3. C. E. Dabrowski, X. Qiu, S. S. Abdel-Meguid
      Pages 95-115
    4. W. F. Mangel, D. L. Toledo, M. T. Brown, J. Ding, R. M. Sweet, D. L. Barnard et al.
      Pages 145-158
    5. J. H. McKerrow, C. R. Caffrey, J. P. Salter
      Pages 189-204
  4. (Non-Viral) Proteases Involved in Diseases

    1. Front Matter
      Pages 205-205
    2. J. D. Becherer, M. H. Lambert, R. C. Andrews
      Pages 235-258
    3. J. C. Cheronis, M. Rabinovitch
      Pages 259-275
    4. A. H. Schmaier
      Pages 277-299
    5. R. Shridhar, B. F. Sloane, D. Keppler
      Pages 301-328

About this book

Keywords

Arzneimittel Chemotherapie HIV Protease RNA chemotherapy drug design enzymes protease inhibitors

Editors and affiliations

  • Klaus von der Helm
    • 1
  • Bruce D. Korant
    • 2
  • John C. Cheronis
    • 3
  1. 1.Max-von-Pettenkofer Institut für medizinische MikrobiologieLM UniversitätMünchenGermany
  2. 2.DuPont Pharmaceutical Co Research and DevelopmentWilmingtonUSA
  3. 3.Drug Discovery and DevelopmentSource Precision MedicineBoulderUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-57092-6
  • Copyright Information Springer-Verlag Berlin Heidelberg 2000
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-63023-1
  • Online ISBN 978-3-642-57092-6
  • Series Print ISSN 0171-2004
  • Series Online ISSN 1865-0325
  • About this book
Industry Sectors
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods
Pharma